+1 866 906 4197
Well known for their portfolio of insulin and insulin delivery devices, Sanofi was looking to expand into the blood glucose monitoring (BGM) market. After a comprehensive search, they selected AgaMatrix as their exclusive BGM partner.
This strategic, long-term partnership allows us to co-develop cutting-edge solutions in diabetes management featuring AgaMatrix's patented WaveSense™ technology. Meters developed for Sanofi have been distributed in more than 15 countries worldwide.
BGStar is a multi-featured meter with mealtime tagging and averaging, alerts for high and low glucose, and positive feedback to indicate in-range results.
BGStar is not available in the U.S.
for outstanding product design in the life science and medicine category
for outstanding product design in the medical category
MyStar Extra includes fasting blood glucose averages and fasting trend arrows to help improve diabetes management.
MyStar Extra is not available in the U.S.
In building our Global Diabetes Division, our objectives included conducting an exhaustive search for potential partners that have excellent core science, are highly innovative, and have the potential to develop a broad range of products. With AgaMatrix, we've found a company that can meet all three objectives in the BGM category.